12:00 AM
 | 
Sep 16, 2013
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Supernus sales and marketing update

Supernus launched Trokendi XR topiramate in the U.S. to treat epilepsy. The extended-release formulation of topiramate, which...

Read the full 71 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >